MBF-118 oral capsules

DRUG2 trials

Sponsors

Medibiofarma S.L.

Conditions

CancerCrohn Disease

Phase 1

Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers

CompletedNCT05921916

Medibiofarma S.L.Cancer

Start: 2020-07-03End: 2022-09-06Updated: 2023-09-21

Phase 2

Safety and Efficacy of MBF-118 in Patients with Crohn Disease

CompletedNCT05940558

Medibiofarma S.L.Crohn Disease

Start: 2023-04-12End: 2024-09-10Updated: 2025-03-03